Semaglutide works by mimicking the effects of GLP-1 (glucagon-like peptide 1), a hormone that helps regulate blood sugar, reduces appetite, and slows down the emptying of the stomach
The early weeks of treatment therefore reflect subtherapeutic drug exposure, and the weight loss observed during this period underestimates what will occur once the full dose is reached
Pick a day and protect it
This analysis provides the information you need to understand what these products actually are, what they contain, how to evaluate them, and whether this category might fit your individual situation.
Protein-rich shakes containing 30 to 40 grams of protein with minimal sugar or fat can be an easy, healthy option when your appetite is low
"FDA's June 2026 Compounding Proposal" refers to the FDA's publicly announced proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period open through June 2026 - this is a factual regulatory event documented in the Federal Register and at FDA.gov, not a determination specific to FeelGood
